Currencies / RDY
RDY: Dr. Reddy's Laboratories Ltd
14.51
USD
0.10
(0.69%)
RDY exchange rate has changed by 0.69% for today. During the day, the instrument was traded at a low of 14.42 and at a high of 14.59.
Follow Dr. Reddy's Laboratories Ltd dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RDY News
- Investing Factbox-Indian textiles, jewellery at risk of 50% Trump tariffs; pharma, phones exempt
- Seeking Alpha Dr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New Revenues (NYSE:RDY)
- Zacks Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
- Zacks Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues
- Investing Dr. Reddy’s stock price target raised to INR1,100 by Jefferies
- Investing Dr. Reddy’s stock price target raised to INR1,200 by Goldman Sachs
- Seeking Alpha Dr. Reddy's Laboratories Limited (RDY) Q1 2026 Earnings Call Transcript
- Seeking Alpha Dr. Reddy's Laboratories Limited 2026 Q1 - Results - Earnings Call Presentation (NYSE:RDY)
- Seeking Alpha Wall Street Lunch: Return Of Meme Stock Frenzy Causes Volatility In The Market
- Investing Dr. Reddy’s Labs ADR earnings missed, revenue fell short of estimates
- Zacks New Strong Sell Stocks for July 18th
- Investing Morgan Stanley initiates coverage on Dr. Reddy’s stock with Equalweight rating
- Investing Macquarie downgrades Dr. Reddy’s stock rating to Neutral on gRevlimid concerns
- Benzinga Why Is Dr Reddy's Stock Trading Higher On Thursday? - Dr Reddy's Laboratories (NYSE:RDY), Alvotech (NASDAQ:ALVO)
- Investing HSBC upgrades Dr Reddy’s on weight loss drug semaglutide-driven earnings rebound
- Investing Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech
- Investing HSBC upgrades Dr. Reddy’s stock rating citing semaglutide prospects
- Seeking Alpha Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY)
- Investing Indian drugmakers fall as Trump says pharma tariffs coming in 2 weeks
- Benzinga Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline - Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE)
- Seeking Alpha Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
- Investing US reciprocal tariffs weigh on India, analysts say
- Seeking Alpha Pfizer Vs. Johnson & Johnson: Who’s The Better Bargain For Investors (NYSE:JNJ)
Daily Range
14.42
14.59
Year Range
12.28
16.41
- Previous Close
- 14.41
- Open
- 14.42
- Bid
- 14.51
- Ask
- 14.81
- Low
- 14.42
- High
- 14.59
- Volume
- 1.542 K
- Daily Change
- 0.69%
- Month Change
- 3.94%
- 6 Months Change
- 13.18%
- Year Change
- -11.42%
25 August, Monday
12:30
USD
- Act
- Fcst
- -0.09
- Prev
- -0.10
14:00
USD
- Act
- Fcst
- 0.688 M
- Prev
- 0.627 M
14:00
USD
- Act
- Fcst
- -2.8%
- Prev
- 0.6%
14:30
USD
- Act
- Fcst
- Prev
15:30
USD
- Act
- Fcst
- Prev
- 4.130%
15:30
USD
- Act
- Fcst
- Prev
- 3.945%
23:15
USD
- Act
- Fcst
- Prev